Cargando…
New Insights into Endometrial Cancer
SIMPLE SUMMARY: Endometrial cancer (EC) represents 90% of uterine cancer and to date its standard clinical approach is still surgery and/or chemo- and radiotherapy. This mini-review illustrates the state of the art in the disease management. In particular, we aim to point out the following features:...
Autores principales: | Paleari, Laura, Pesce, Silvia, Rutigliani, Mariangela, Greppi, Marco, Obino, Valentina, Gorlero, Franco, Vellone, Valerio Gaetano, Marcenaro, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037936/ https://www.ncbi.nlm.nih.gov/pubmed/33804979 http://dx.doi.org/10.3390/cancers13071496 |
Ejemplares similares
-
NK Cell-Based Immunotherapy in Colorectal Cancer
por: Della Chiesa, Mariella, et al.
Publicado: (2022) -
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy
por: Pesce, Silvia, et al.
Publicado: (2020) -
Female Malignancies and Immunotherapy: What’s New?
por: Pesce, Silvia, et al.
Publicado: (2020) -
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the art
por: Provinciali, Nicoletta, et al.
Publicado: (2022) -
Harnessing NK Cells for Cancer Treatment
por: Minetto, Paola, et al.
Publicado: (2019)